Neurodegenerative Diseases Related Content

The World Health Organization, says recognising dementia as a public health priority is key to addressing the condition globally

Writing on behalf of the Chartered Society of Physiotherapy, Dr. Bhanu Ramaswamy highlights how physiotherapy can help manage the symptoms of Parkinson’s

Frederic Destrebecq, Vinciane Quoidbach and Alison Turner at the European Brain Council discuss improvements in stroke care, awareness-raising and early detection Stroke is a leading cause of disability and mortality among adults. It is the third cause of death worldwide and the first cause of acquired disability.1 Despite improvements in...

Dr Mehis Pilv, CEO and business development lead at Genecode, discusses the strides being made in Parkinson's disease research Parkinson's disease is a slow but progressive neurodegenerative disorder. About 1% of people aged above 50 are affected worldwide. In Europe alone 1.2 million people suffer from Parkinson's disease, 127,000 of whom...

The changing pharma landscape means opportunities for Parkinson's drug discovery are missed, but Parkinson's UK has a new strategy to redress the balance This will be the 200th year since James Parkinson wrote his seminal paper on ‘the Shaking Palsy’. Since that time there have been major developments in the...

AriSLA – The Italian Research Foundation for ALS, outlines strides made in ALS research in Italy over the last 10 years and work still needed to find a cure Amyotrophic lateral sclerosis (ALS) is the most common adult-onset neurodegenerative disease, characterised by progressive loss of upper and lower motor neurons...

Professor Serena Carra and her collaborators are investigating the important role of small heat shock proteins in age-related neurodegenerative diseases Cells are frequently exposed to stress conditions that can damage their proteome, with consequences for their viability. To maintain a healthy proteome and preserve cell function, cells evolved a protein...

UCB's Duncan McHale outlines why reclassification might be a good idea to boost drug development for neurodegenerative diseases like Alzheimer's and Parkinson's Neurodegenerative diseases are a growing global challenge, as medical advances ensure more individuals live longer. By 2020 there will be more than 40 million people in the world...